Rhumbline Advisers Avrobio, Inc. Transaction History

Rhumbline Advisers

$103 Billion
Q1 2024

A detailed history of Rhumbline Advisers transactions in Avrobio, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 1,208 shares of AVRO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,208

Previous 1,208 -0.0%

Holding current value

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.58 - $1.31 $700 - $1,582	1,208 New	1,208 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.75 - $1.33 $34,936 - $61,954	-46,582 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.29 - $4.04 $6,034 - $18,899	-4,678 Reduced 9.13%	46,582 $61,000
Q4 2021 Feb 10, 2022	SELL	$3.45 - $6.05 $2,380 - $4,174	-690 Reduced 1.33%	51,260 $197,000
Q3 2021 Nov 12, 2021	BUY	$5.53 - $9.28 $11,170 - $18,745	2,020 Added 4.05%	51,950 $290,000

Q2 2021 Aug 05, 2021	BUY	$7.84 - $12.6 $101,112 - $162,502	12,897 Added 34.83%	49,930 $444,000
Q1 2021 May 06, 2021	SELL	$10.54 - $19.3 $10,013 - $18,335	-950 Reduced 2.5%	37,033 $470,000
Q4 2020 Feb 10, 2021	BUY	$12.79 - $17.1 $29,289 - $39,159	2,290 Added 6.42%	37,983 $529,000
Q3 2020 Nov 12, 2020	SELL	$12.99 - $19.41 $50,453 - $75,388	-3,884 Reduced 9.81%	35,693 $465,000
Q2 2020 Aug 13, 2020	BUY	$12.19 - $22.96 $183,422 - $345,479	15,047 Added 61.34%	39,577 $691,000
Q1 2020 May 06, 2020	BUY	$10.08 - $27.21 $25,835 - $69,739	2,563 Added 11.67%	24,530 $382,000
Q4 2019 Feb 05, 2020	BUY	$13.05 - $21.88 $14,002 - $23,477	1,073 Added 5.14%	21,967 $442,000
Q3 2019 Oct 23, 2019	BUY	$14.12 - $23.44 $36,260 - $60,193	2,568 Added 14.01%	20,894 $295,000
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $64,781 - $133,830	4,904 Added 36.54%	18,326 $298,000
Q1 2019 May 01, 2019	BUY	$12.46 - $22.05 $167,238 - $295,955	13,422 New	13,422 $296,000
Q4 2018 Jan 31, 2019	SELL	$15.43 - $32.7 $69,944 - $148,229	-4,533 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$26.95 - $52.7 $122,164 - $238,889	4,533 New	4,533 $235,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

28.1M

Call Options Held

Put Options Held

100

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Avrobio, Inc. Transaction History